Clinical Trial: Tofacitinib in the Treatment of Refractory Axial Spondyloarthritis Patients: A Dose Escalation Study
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Axial Spondyloarthritis
Study Type: INTERVENTIONAL
Official Title: Tofacitinib in the Treatment of Refractory Axial Spondyloarthritis Patients: A Dose Escalation Study
Brief Summary:
The goal of this clinical trial is to assess the efficacy of tofacitinib in refractory axial spodyloarthritis (ax-SpA) with dose escalation from 10mg to 15mg.Patients will start on 10mg and then divided into 2 groups (10 and 15) at 3rd month according to major improvement criteria.The main question[s] it aims to answer are:Efficacy and safety of tofacitinib in different dosesIf escalation of tofacitinib is justified if clinical criteria is not fulfilled at 10mg
Read more